%0 Journal Article
%T 残余胆固醇与血液透析患者血脂异常的现况<br>Remnant Cholesterol and Status of Dyslipidemia in Hemodialysis Patients
%A 杜柯锐
%A 侯显玥
%A 杨小娟
%J Advances in Clinical Medicine
%P 6106-6112
%@ 2161-8720
%D 2022
%I Hans Publishing
%R 10.12677/ACM.2022.127880
%X 血液透析(HD)已成为大多数终末期肾病患者偏向选择的肾脏替代方式，心血管疾病(CVD)是其主要死亡原因。脂代谢紊乱是CVD和终末期肾病(ESRD)共同进展的机制。越来越多的证据表明，即使当低密度脂蛋白控制到最佳水平，残余胆固醇(RC)仍从流行病学及遗传学等方面被证明在预测ASCVD的发生中起着重要作用。现就HD患者血脂紊乱的特点及RC的定义、测量、机制、相关研究进展等进行总结。<br />
Hemodialysis (HD) has become the preferred renal replacement for most patients with end-stage renal disease, and cardiovascular disease (CVD) is the leading cause of death. Dyslipidemia is a mechanism for the co-progression of CVD and end-stage renal disease (ESRD). There is increasing evidence that even when low-density lipoprotein is controlled to optimal levels, remnant cholester-ol (RC) is still proven to play an important role in predicting the occurrence of ASCVD from the as-pects of pathogenic mechanism, epidemiology and genetics. This article summarizes the character-istics of dyslipidemia in HD patients and the definition, measurement, mechanism, and related re-search progress of RC.
%K 残余胆固醇，终末期肾脏病，血液透析，心血管疾病，脂代谢紊乱<br>Remnant Cholesterol
%K End-Stage Renal Disease
%K Hemodialysis
%K Atherosclerotic Cardiovascular Dis-ease
%K Dyslipidemia
%U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=53324